Brazil Threatens U.S. AIDS Drug Makers With Compulsory Licensing

Law360, New York (March 16, 2005, 12:00 AM EST) -- Raising the specter of compulsory licensing, Brazil's government health ministry has given U.S. drug makers Abbot Laboratories, Merck & Co. and Gilead Sciences Inc. until April 4 to agree on a schedule to transfer technology for the production of some of their AIDS drugs.

The drugs in question, Abbott's combination pill of the protease inhibitors Lopinavir and Ritonavir, Merck & Co's reverse transcriptase inhibitor Efavirenz, and Gilead Science Inc.'s Tenofovir, account for two thirds of the government's budget for imported AIDS drugs.

If the companies don't...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.